The Ruby Red Foundation announces its inaugural series of research grants in line with its primary objective of directing funding to further research into Myeloproliferative Neoplasms (MPN’s). The grants were awarded following a competitive request for proposal by the Foundation earlier this year to institutions with an interest in MPN research.
The Foundation is pleased to congratulate the University of Western Australia and Monash University for being successful in this first-round of seed funding.
“The focus is on supporting research that will have a direct impact on understanding the drivers of disease progression in MPNs and identifying new targets in the pursuit of breakthrough treatments” said Dr Laura Issa, Non-Executive Director for the Foundation and heads the Research Advisory Group.
For more information, please see the official Press Release.